Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
China channel feed
A Chinese company is already mass producing Gilead's experimental coronavirus drug
6 years ago
Coronavirus
China researchers tout in vitro data for Gilead's antiviral against Wuhan virus — which they are trying to patent
6 years ago
Pandemic fears force Chinese biotech to postpone Hong Kong IPO meetings — Bloomberg
6 years ago
Financing
Vas Narasimhan wants Novartis to have a big focus on China. Here’s what that looks like
6 years ago
Pharma
How do American scientists get embroiled in China scandals? Moffitt investigation sheds some light
6 years ago
People
Top Harvard chemist caught up in FBI’s 'Thousand Talents' dragnet, accused of lying about Chinese connections, pay
6 years ago
People
AbbVie donates $1M+ of the HIV drug that China is now recommending for coronavirus treatment
6 years ago
Coronavirus
Amgen augments Asia foothold by taking over Astellas joint venture in Japan
6 years ago
Deals
Roche cracks China's ADC market open as Kadcyla scores its first breast cancer OK in the country
6 years ago
Pharma
China’s fourth richest man takes a back seat at the top drugmaker he built
6 years ago
People
Biopharma's China plan gets a boost from patent protections sealed in now official trade deal
6 years ago
FDA+
WuXi-backed Adagene scores $69M round led by General Atlantic to push antibodies where Bristol-Myers struggled
6 years ago
Financing
BeiGene scores first China OK with PD-1 — to be manufactured by Boehringer Ingelheim
6 years ago
Pharma
China greenlights homegrown pneumococcal, HPV vaccines for the market — breaking grips by Pfizer, Merck
6 years ago
FDA+
Chinese court sentences Jiankui He to 3 years in jail — and confirms birth of 3rd CRISPR baby
6 years ago
Cell/Gene Tx
Banking on Shanghai's biotech boom, this Eli Lilly-backed player grabs $100M to push next-gen I/O therapies
6 years ago
Financing
Startups
NIH-directed purge of researchers with China ties sweeps up Moffitt CEO Alan List, colleagues
6 years ago
Discovery
BeiGene's BTK inhibitor fails to beat market leader Imbruvica in key head-to-head study
6 years ago
R&D
AstraZeneca joins Merck, Bristol-Myers in China's checkpoint race as regulators OK first PD-L1
6 years ago
Pharma
Alphamab Oncology rounds out HKEX's second biotech IPO year with $230M raise and high local interest
6 years ago
Financing
Shaking up China's PD-(L)1 reimbursement landscape, Innovent, Eli Lilly earn coveted spot on national coverage
6 years ago
Pharma
Roche shows Tecentriq/Avastin combo helps liver cancer patients live longer
6 years ago
R&D
Brii Bio backs infectious disease startup while inking deal for its lead TB drug, doubling down on antibiotics
6 years ago
Deals
In a first, FDA green-lights use of a Chinese built cancer therapy — and more are coming
6 years ago
FDA+
First page
Previous page
18
19
20
21
22
23
24
Next page
Last page